The Pharmaceutical Intellectual Property and Competition Law Review – Update: Christopher Weber und Dr. Benjamin Pesch publish on recent developments in intellectual property and competition law in the pharmaceutical sector in Germany

This latest 4. edition of The Pharmaceutical Intellectual Property and Competition Law Review, our partner Christopher Weber and our counsel Dr Benjamin Pesch have published another chapter on current developments in the German market, based on their expertise in the pharmaceutical sector.

In Chapter 5, they provide an update on the general principles and recent developments in intellectual property and competition law in the pharmaceutical sector in Germany. A detailed insight into the German chapter can be found here.

Excerpts of the publication are also published as part of our partnership on Lexology. If you are interested in a bound copy of the book, please contact our two authors:

weber@katheraugenstein

pesch@katheraugenstein

The Pharmaceutical Intellectual Property and Competition Law Review is an annual hardcover and online guide covering legal and market developments in key jurisdictions in the pharmaceutical sector worldwide. As an “annual review”, the publication provides a detailed analysis of recent developments in legislation and its interpretation by national authorities around the world and aims to give users an insight into future trends.

About the Law Reviews:

The Law Reviews is a network of experts covering over 108 areas of law in more than 130 countries worldwide, aimed at practitioners looking beyond their own borders for strategic solutions in foreign jurisdictions.

Progressive thinkers from the world’s leading law firms analyse global legal issues and their business implications. The Law Reviews is an essential resource for lawyers, in-house counsel, governments and corporate executives.

The editors of The Law Reviews are recognised international industry experts in key practice areas.